Myovant

Sumitomo nets Myovant in $2.9B buyout, adding IVF asset to pipeline
Fierce Biotech
Mon, 10/24/22 - 11:20 pm
Sumitomo Pharma
M&A
Myovant
IVF
In Vitro Fertilization
Orgovyx
Myfembree
Sumitomo Offers to Buy All of Myovant in $2.5 Billion Deal
Yahoo/Bloomberg
Mon, 10/3/22 - 10:24 am
Sumitomo Pharma
M&A
Myovant
Pfizer and Myovant’s endometriosis pain drug Myfembree gets another FDA nod
Endpoints
Mon, 08/8/22 - 11:28 pm
Pfizer
Myovant
FDA
Myfembree
endometriosis
Myovant and Pfizer’s path to securing a second nod for Myfembree gets hazy — and investors react quickly  
Endpoints
Tue, 04/12/22 - 10:48 am
Myovant
Myfembree
Pfizer
endometriosis
ObsEva files uterine fibroid drug in US, chasing AbbVie, Myovant
Pharmaforum
Wed, 09/15/21 - 10:46 am
ObsEva
uterine fibroids
AbbVie
Myovant
FDA
linzagolix
Pfizer/Myovant take relugolix contraceptive combination pill into phase 3
Pharmaforum
Wed, 04/14/21 - 09:32 am
Pfizer
Myovant
Relugolix
contraceptives
clinical trials
Myovant/Pfizer's Relugolix Combo Therapy Shows Sustained Clinical Benefit In Uterine Fibroids
Benzinga
Wed, 03/24/21 - 10:16 am
Myovant
Pfizer
clinical trials
Relugolix
uterine fibroids
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
PR Newswire
Tue, 03/9/21 - 10:45 am
Clarivate
Biogen
Eisai
aducanumab
UCB Pharma
bimekizumab
Relugolix
Pfizer
Takeda
Myovant
vericiguat
Bayer
Merck
With FDA Approval and Pfizer Deal in Hand, Myovant Appoints New CEO
BioSpace
Mon, 01/4/21 - 10:55 pm
Myovant
FDA
Pfizer
David Marek
Lynn Seely
Myovant Up on $4.2B Pfizer Pact to Develop Prostate-Cancer Drug
TheStreet.com
Mon, 12/28/20 - 10:42 am
Myovant
Pfizer
prostate cancer
Orgovyx
Relugolix
Myovant shows disappointing prostate cancer data on the way to the FDA, stock sinks
Endpoints
Tue, 09/29/20 - 12:13 pm
Myovant
Relugolix
prostate cancer
AbbVie
Lupron
clinical trials
Looking at a groundbreaking advance, Myovant gets a priority review at FDA
Endpoints
Mon, 06/22/20 - 11:10 am
Myovant
FDA
priority review
Relugolix
prostate cancer
ASCO: Myovant details speedy effects of prostate cancer med relugolix
Fierce Biotech
Mon, 06/1/20 - 10:45 am
Myovant
ASCO 2020
Relugolix
prostate cancer
clinical trials
Upcoming events – Pfizer's abrocitinib and Myovant's relugolix
EP Vantage
Sat, 01/11/20 - 12:01 am
Pfizer
abrocitinib
Dupixent
Sanofi
Myovant
Relugolix
uterine fibroids
Vivek Ramaswamy trades top execs and adds stealthy vant to $3B sale, while his new partner tosses Myovant $350M
Endpoints
Thu, 10/31/19 - 10:50 am
Vivek Ramaswamy
Sumitomo Dainippon
Myovant
Myovant's uterine fibroid drug looks competitive in PhIII — but can they vanquish mighty AbbVie?
Endpoints
Tue, 07/23/19 - 10:05 am
Myovant
uterine fibroids
Relugolix
AbbVie
Elagolix
This drug may be able to treat both women’s health disorders and prostate cancer
Marketwatch
Thu, 10/12/17 - 09:31 am
Myovant
Relugolix
prostate cancer
uterine fibroids
endometriosis
Turning pharma castoffs into an instant fortune, Vivek Ramaswamy’s Myovant bags a $218M IPO
Endpoints
Thu, 10/27/16 - 09:20 am
IPOs
Vivek Ramaswamy
Myovant